329 related articles for article (PubMed ID: 27293068)
1. Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion.
Sertedaki A; Markou A; Vlachakis D; Kossida S; Campanac E; Hoffman DA; Sierra ML; Xekouki P; Stratakis CA; Kaltsas G; Piaditis GP; Chrousos GP; Charmandari E
Clin Endocrinol (Oxf); 2016 Dec; 85(6):845-851. PubMed ID: 27293068
[TBL] [Abstract][Full Text] [Related]
2. Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential Hypertension.
Markou A; Sertedaki A; Kaltsas G; Androulakis II; Marakaki C; Pappa T; Gouli A; Papanastasiou L; Fountoulakis S; Zacharoulis A; Karavidas A; Ragkou D; Charmandari E; Chrousos GP; Piaditis GP
J Clin Endocrinol Metab; 2015 Aug; 100(8):2857-64. PubMed ID: 25974737
[TBL] [Abstract][Full Text] [Related]
3. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone-Regulating Receptors and Aldosterone-Driver Somatic Mutations.
Lim JS; Plaska SW; Rege J; Rainey WE; Turcu AF
Front Endocrinol (Lausanne); 2021; 12():644382. PubMed ID: 33796077
[TBL] [Abstract][Full Text] [Related]
5. a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III.
Monticone S; Hattangady NG; Penton D; Isales CM; Edwards MA; Williams TA; Sterner C; Warth R; Mulatero P; Rainey WE
J Clin Endocrinol Metab; 2013 Nov; 98(11):E1861-5. PubMed ID: 24037882
[TBL] [Abstract][Full Text] [Related]
6. Genetic, Cellular, and Molecular Heterogeneity in Adrenals With Aldosterone-Producing Adenoma.
De Sousa K; Boulkroun S; Baron S; Nanba K; Wack M; Rainey WE; Rocha A; Giscos-Douriez I; Meatchi T; Amar L; Travers S; Fernandes-Rosa FL; Zennaro MC
Hypertension; 2020 Apr; 75(4):1034-1044. PubMed ID: 32114847
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
Monticone S; Castellano I; Versace K; Lucatello B; Veglio F; Gomez-Sanchez CE; Williams TA; Mulatero P
Mol Cell Endocrinol; 2015 Aug; 411():146-54. PubMed ID: 25958045
[TBL] [Abstract][Full Text] [Related]
8. Different cell compositions and a novel somatic
Zhao L; Wan J; Wang Y; Yang W; Liang Q; Wang J; Jin P
Front Endocrinol (Lausanne); 2023; 14():1068335. PubMed ID: 36960396
[TBL] [Abstract][Full Text] [Related]
9. Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production.
Hattangady NG; Karashima S; Yuan L; Ponce-Balbuena D; Jalife J; Gomez-Sanchez CE; Auchus RJ; Rainey WE; Else T
J Mol Endocrinol; 2016 Jul; 57(1):1-11. PubMed ID: 27099398
[TBL] [Abstract][Full Text] [Related]
10. Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism.
Murthy M; Xu S; Massimo G; Wolley M; Gordon RD; Stowasser M; O'Shaughnessy KM
Hypertension; 2014 Apr; 63(4):783-9. PubMed ID: 24420545
[TBL] [Abstract][Full Text] [Related]
11. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
Kuppusamy M; Caroccia B; Stindl J; Bandulik S; Lenzini L; Gioco F; Fishman V; Zanotti G; Gomez-Sanchez C; Bader M; Warth R; Rossi GP
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
[TBL] [Abstract][Full Text] [Related]
12. Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance.
Cheng CJ; Sung CC; Wu ST; Lin YC; Sytwu HK; Huang CL; Lin SH
J Clin Endocrinol Metab; 2015 Jan; 100(1):E155-63. PubMed ID: 25347571
[TBL] [Abstract][Full Text] [Related]
13. Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series.
Fallo F; Castellano I; Gomez-Sanchez CE; Rhayem Y; Pilon C; Vicennati V; Santini D; Maffeis V; Fassina A; Mulatero P; Beuschlein F; Reincke M
Endocrine; 2017 Dec; 58(3):503-512. PubMed ID: 28405879
[TBL] [Abstract][Full Text] [Related]
14. A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension.
Charmandari E; Sertedaki A; Kino T; Merakou C; Hoffman DA; Hatch MM; Hurt DE; Lin L; Xekouki P; Stratakis CA; Chrousos GP
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1532-9. PubMed ID: 22628607
[TBL] [Abstract][Full Text] [Related]
15. Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.
Fernandes-Rosa FL; Williams TA; Riester A; Steichen O; Beuschlein F; Boulkroun S; Strom TM; Monticone S; Amar L; Meatchi T; Mantero F; Cicala MV; Quinkler M; Fallo F; Allolio B; Bernini G; Maccario M; Giacchetti G; Jeunemaitre X; Mulatero P; Reincke M; Zennaro MC
Hypertension; 2014 Aug; 64(2):354-61. PubMed ID: 24866132
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a mutated KCNJ5 gene, G387R, in unilateral primary aldosteronism.
Chueh JS; Peng KY; Wu VC; Wang SM; Chan CK; Chen YM; Ke YY; Pan CY; Liao HW
J Mol Endocrinol; 2021 Sep; 67(4):203-215. PubMed ID: 34463641
[TBL] [Abstract][Full Text] [Related]
17. Primary Aldosteronism: Spatial Multiomics Mapping of Genotype-Dependent Heterogeneity and Tumor Expansion of Aldosterone-Producing Adenomas.
Gong S; Sun N; Meyer LS; Tetti M; Koupourtidou C; Krebs S; Masserdotti G; Blum H; Rainey WE; Reincke M; Walch A; Williams TA
Hypertension; 2023 Jul; 80(7):1555-1567. PubMed ID: 37125608
[TBL] [Abstract][Full Text] [Related]
18. Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White Americans.
Nanba K; Omata K; Else T; Beck PCC; Nanba AT; Turcu AF; Miller BS; Giordano TJ; Tomlins SA; Rainey WE
J Clin Endocrinol Metab; 2018 Oct; 103(10):3869-3876. PubMed ID: 30085035
[TBL] [Abstract][Full Text] [Related]
19. Familial forms and molecular profile of primary hyperaldosteronism.
Araujo-Castro M; Martín Rojas-Marcos P; Parra Ramírez P
Hipertens Riesgo Vasc; 2022; 39(4):167-173. PubMed ID: 35778363
[TBL] [Abstract][Full Text] [Related]
20. [Primary aldosteronism: new insights into familial forms].
van den Meiracker AH; van der Linde AA; Claahsen van der Grinten HL; Danser AH; Deinum J
Ned Tijdschr Geneeskd; 2015; 159():A8932. PubMed ID: 26420144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
